1. Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. Issue 5 (26th February 2018) Authors: Taylor, Peter C; Schiff, Michael H; Wang, Qingmin; Jiang, Yusang; Zhuang, Yanli; Kurrasch, Regina; Daga, Shruti; Rao, Ravi; Tak, Paul P; Hsu, Benjamin Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 5(2018) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration. Issue 8 (12th April 2014) Authors: Schiff, Michael H; Jaffe, Jonathan S; Freundlich, Bruce Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 8(2014) Page Start: 1549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Response to: 'Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?' by Fleishman and Yazici. Issue 9 (24th June 2014) Authors: Schiff, Michael H; Jaffe, Jonathan S; Freundlich, Bruce Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 9(2014) Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Issue 12 (27th June 2014) Authors: Schiff, Michael H; von Kempis, Johannes; Goldblum, Ronald; Tesser, John R; Mueller, Ruediger B Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 12(2014) Page Start: 2174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. (1st November 2000) Authors: Schiff, Michael H Journal: Annals of the rheumatic diseases Issue: Volume 59(2000)Supplement 1 Page Start: i103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗